Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM TrialFrançois‐Xavier Sibille, Anne Spinewine, Marie de Saint‐Hubert et al.|Drugs & Aging|2023Cited by 12
Clinical appraisal of STOPP/START version 3 criteriaBenoît Boland, Olivia Dalleur, Stuart Locke et al.|European Geriatric Medicine|2023Cited by 7
Reversible Akinetic Mutism after Aneurysmal Subarachnoid Haemorrhage in the Territory of the Anterior Cerebral Artery without Permanent Ischaemic Damage to Anterior Cingulate GyriFrançois‐Xavier Sibille, Simone Giglioli, Philippe Hantson et al.|Case Reports in Neurological Medicine|2016Cited by 5
Improving usability of the STOPP/START version 3 criteria: development of a practice tool for clinicians, students and researchersOlivia Dalleur, Barbara A. Boland, François‐Xavier Sibille et al.|European Geriatric Medicine|2025Cited by 5
Equipping physicians for benzodiazepine receptor agonists deprescription in older adults: theory-based development of the BE-SAFE interventionFrançois‐Xavier Sibille, Marie de Saint Hubert, Joanna Salbert et al.|Research in Social and Administrative Pharmacy|2025Cited by 3